Pharmacological Treatment of Giardiasis
( Current Topics in Giardiasis )
Publication series ： Current Topics in Giardiasis
Author： Víctor Manuel Molina Díaz
Publisher： IntechOpen
Publication year： 2017
E-ISBN: INT6518271803
P-ISBN(Paperback): 9789535136538
P-ISBN(Hardback): 9789535136545
Subject： R18 Epidemiology and Preventive Medicine;R51 infectious diseases
Keyword： 传染病,流行病学与防疫
Language： ENG
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Pharmacological Treatment of Giardiasis
Description
Giardiasis is a disease caused for a myoflagellate protozoan known as Giardia duodenalis, of which varieties have been described and whose morphological characteristics are identical to other species such as G. lamblia and G. intestinalis; considered for various authors as the same species, this protozoan parasites several domestic species including man, but has important relevance in the canine and feline species, due to their zoonotic potential. In recent years, the number of cases of canine and feline giardiasis has increased, not only because it is treated of a cosmopolitan parasite, which is closely related to unsanitary conditions, but also because the conventional treatments for its control and eradication have shown resistance phenomena. It is for this reason and being a parasite of potential zoonotic risk that at present pharmacological tests have been developed in the search for new alternatives for the treatment of giardiasis, especially in the canine and feline species as mentioned earlier.
Chapter